Bangladesh to discuss Oxford University’s COVID-19 vaccine trial with India

Dhaka is set to discuss the trial of Oxford University’s COVID-19 vaccine, millions of doses of which will be produced by India’s Serum Institute if successful in tests, in Bangladesh

Aug 19, 2020
Image
a

Dhaka is set to discuss the trial of Oxford University’s COVID-19 vaccine, millions of doses of which will be produced by India’s Serum Institute if successful in tests, in Bangladesh.

Foreign Secretary Masud Bin Momen told the media on Tuesday that he would make the offer in his meeting with his visiting Indian counterpart Harsh Vardhan Shringla on Wednesday.

Momen said Bangladesh also communicated with Britain’s AstraZeneca via the High Commission in London with the offer for the trial to be held in Bangladesh.

Developed in collaboration with British pharmaceutical company AstraZeneca, Oxford University’s vaccine candidate is leading the race for a vaccine seen as the only viable option to get the world out of the coronavirus pandemic.

The vaccine is undergoing final stage trials in different countries. Serum Institute is also set to begin trials of the vaccine in India this week, the country’s media reported.

https://bdnews24.com/bangladesh/2020/08/18/bangladesh-to-discuss-oxford-universitys-covid-19-vaccine-trial-with-india

Post a Comment

The content of this field is kept private and will not be shown publicly.